2004 Pocket Book of Infectious Disease Therapy 12th ed - J. Bartlett (2004) WW PDF
Preview 2004 Pocket Book of Infectious Disease Therapy 12th ed - J. Bartlett (2004) WW
Front of Book 1 Editors 2 PREFACE Table of Contents Antimicrobial Agents 3 Preparations and Recommended Dosing Regimens for Antimicrobial Agents 4 Prefered Antimicrobial Agents for Specific Pathogens 5 Antimicrobial Dosing Regimens in Renal Failure 6 Use of Antimicrobial Agents in Hepatic Disease 7 Adverse Reactions to Antimicrobial Agents 8 Drug Interactions Preventive Treatment 9 Adult Immunization Schedule 10 Prophylactic Antibiotics in Surgery 11 Antimicrobial Prophylaxis in Ambulatory Patients 12 Prevention of Bacterial Endocardits 13 Prevention of Diseases Associated with Travel Nonbacterial Infections 14 Treatment of Fungal Infections 15 Treatment of Mycobacterial Infections 16 Drugs for Treatment of Parasitic Infections 17 Treatment of Viral Infections Specific Infections 18 Sepsis and Sepsis Syndrome 19 Compromised Host 20 Toxic Shock Syndrome: Case Definition of Cdc (MMWR 29:229, 1980) 21 Group A Streptococcal Infections 22 Anaerobic Infections 23 Fever of Unknown Origin 24 Treatment of Lyme Disease and Potential Exposures 25 Infections of Epidermis, Dermis, and Subcutaneous Tissue 26 Deep Serious Soft Tissue Infections 27 Bone and Joint Infections 28 Ocular and Periocular Infections 29 Infections of Central Nervous System 30 Upper Respiratory Tract Infections 31 Pulmonary Infections 32 Endocarditis 33 Viral Hepatitis 34 Intra-Abdominal Sepsis: Antibiotic Selection 35 Helicobacter pylori: Treatment of Peptic Ulcer Disease 36 Infectious Diarrhea 37 Foodborne Outbreaks 38 Urinary Tract Infections 39 Sexually transmitted diseases 40 Duration of Antibiotic Treatment 41 Trade Names of Antimicrobial Agents Back of Book INDEX 42 A 43 B 44 C 45 D 46 E 47 F 48 G 49 H 50 I 51 J 52 K 53 L 54 M 55 N 56 O 57 P 58 Q 59 R 60 S 61 T 62 U 63 V 64 W 65 X 66 Y 67 Z Editors: Bartlett, John G. Title: 2004 Pocket Book of Infectious Disease Therapy, 12th Edition Copyright ©2004 Lippincott Williams & Wilkins > Front of Book > Editors Editor John G. Bartlett M.D. Professor of Medicine; Chief Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland Secondary Editors Jim Merritt Acquisitions Editor Raymond E. Reter Developmental Editor Jennifer Jett Purchasing Manager Clinical and Healthcare Typesetter: Peirce Graphic Services, LLC Printer: Transcontinental Editors: Bartlett, John G. Title: 2004 Pocket Book of Infectious Disease Therapy, 12th Edition Copyright ©2004 Lippincott Williams & Wilkins > Front of Book > PREFACE PREFACE The 2004 Pocket Book of Infectious Disease Therapy is intended for physicians and other care providers who manage adult patients with infectious diseases. These include internists, generalists, surgeons, obstetricians, gynecologists, medical sub-specialists, and surgical subspecialists. This book has the same lofty goals as the first eleven editions: to provide standards of care for the management of infectious disease with particular emphasis on antimicrobial agents, their selection, dosing regimens, costs, and side effects. As with prior editions, there is extensive use of recommendations from various authoritative sources such as the Centers for Disease Control and Prevention (CDC) and the Medical Letter on Drugs and Therapeutics and from official statements of learned societies such as the American College of Physicians/American Society of Internal Medicine (ACP/ASIM), the American Heart Association (AHA), the American Thoracic Society (ATS), the Infectious Diseases Society of America (IDSA), and the Surgical Infection Society (SIS). The 2004 edition has extensive additions, deletions, and revisions. Tabular material has been updated to account for recently approved antibiotics and new recommendations for management. This edition includes topical issues such as severe acute respiratory syndrome (SARS), West Nile Virus, hepatitis C virus (HCV), and bioterrorism. It also contains the new guidelines for intraabdominal sepsis, IV catheter-associated sepsis, fever of unknown origin, fever in the neutropenic cancer patient, and HCV management. Antimicrobials introduced since the tenth edition that are now included are peginterform, valganciclovir, adefovir, caspofungin, voriconazole, cefditoren, ertapenem, and nitazoxanide. The HIV/AIDS section has been deleted because of space constraints and the availability of an alternative resource: Medical Management of HIV Infection by this author. The reader is encouraged to notify the author (1830 Monument Street, Room 437, Baltimore, MD 21205, 410-955-7634) if there are errors, differences of opinion, or suggested additions. The reader is also encouraged to visit the Johns Hopkins website for updated information. For material related to HIV/AIDS: http://www.hopkins-aids.edu; for maaterial related to general infectious diseases: http://www.hopkins-id.edu. Use for management guidance http://www.hopkins-abxguide.org, which is also availaable with hand-held devices. Editors: Bartlett, John G. Title: 2004 Pocket Book of Infectious Disease Therapy, 12th Edition Copyright ©2004 Lippincott Williams & Wilkins > Table of Contents > Antimicrobial Agents > Preparations and Recommended Dosing Regimens for Antimicrobial Agents Preparations and Recommended Dosing Regimens for Antimicrobial Agents (Adapted from Drug Information 03, American Hospital Formulary Service, 2003; Physicians' Desk Reference, 57th Edition, 2003; and Drug Information for the Health Care Professional, USP DI, 23rd Edition, 2003) Agent (generic) Pregnancy category* Trade names Dosage form Usual adult regimen and AWP** Acyclovir Category C*** Zovirax 5% ointment; 2 & 15 g tubes 200 mg cap 400 & 800 mg tabs 200 mg/5 mL susp 500 & 1000 mg vials (IV) Topical q3h 2 g @ $35.28 200 mg po; × 3–5/d 200 mg @ $1.12 400 mg po bid 800 mg po × 5/d 800 mg @ $4.21 200–800 mg po × 3–5/d 15–30 mg/kg/d IV over 1 hr q8h 1 g @ $35.00 Adofovir Category C Hepsera 10 mg tab 10 mg po qd × 48–92 wks 10 mg @ $17.60 Albendazole Category C Albenza 200 mg tabs 400 mg po bid 200 mg @ $1.49 Amantadine Category C Symmetrel Symadine 100 mg cap 50 mg/5 mL soln 200 mg qd or 100 mg bid (treatment or prophylaxis); 100 mg/d age > 65 yr 100 mg @ $0.62 Amikacin Category D Amikin 0.1, 0.5 & 1 g vials 15 mg/kg/d IV × 1/d or q8–12h 500 mg @ $119.60 Aminosalicylic acid* Paser granules 4 g packet 150 mg/kg/d po q6–12h Amoxicillin Category B Amoxil, Trimox, Wymox 250 & 500 mg caps 125 & 250 mg/5 mL susp 250–500 mg po tid 250 mg @ $0.25 500 mg @ $0.43 Amoxicillin + clavulanate Category B Augmentin 125/31 & 250/62 mg/5 mL susp 125/31 & 250/62 mg chewable tab 250–250/125 & 500/125 mg tab 875/125 mg tab 250–500 mg po tid (amoxicillin) 875/15 mg @ $5.84 500/125 mg @ $4.22 875/125 mg po bid Amphotericin B Category B Fungizone 50 mg vial 0.3–1 mg/kg/d IV over 4–6 hr 50 mg @ $10.94 Amphotericin B Abelcet (ABLC) 100 mg vials 5 mg/kg/d IV 100 mg @ $230.00
The list of books you might like
